Immunology, Microbiology & IBD
Dear Member of the Immunology, Microbiology & Inflammatory Bowel Diseases Section and interested others:
We thank you for attending the 41st annual DDW® in New Orleans, LA and making it a scientifically relevant and exciting meeting! If you have specific feedback regarding speakers sponsored by the Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section at DDW, please share your thoughts with us. We will do our best to consider your comments and concerns as we plan our program for next DDW 2011 in Chicago.
One of our section's abstracts "The Crohn's Disease protective SNP rs11209026 allele "A" mediates alternative splicing in human IL23R transcription." was presented at the successful AGA Institute Basic Science Plenary Session.
We would like to welcome the newly elected Immunology, Microbiology & Inflammatory Bowel Diseases Section Vice-Chair, Maria T. Abreu, MD. And the newly elected Nominating Committee Members: David T. Rubin, MD, AGAF; Uma Mahadevan , MD; Jean Frederick Colombel, MD; and Gert Van Assche, MD, PhD. We would also like to thank R. Balfour Sartor, MD for his invaluable service as Chair of the Immunology, Microbiology & Inflammatory Bowel Diseases Section from 2008-2010. Thank you to all those who participated in the election and voted.
This year the IMIBD section accepted the majority of the abstracts submitted. The accepted abstracts were designated as oral or poster presentations and of distinction based on their ranking by our dedicated abstract reviewers.
| IMIBD Abstract Selection | 2010 |
| Total Abstracts submitted | 911 |
| Accepted Abstracts | 692 |
| Oral Presentations | 127 |
| Posters | 565 |
| Posters of Distinction | 68 |
IMIBD sponsored Clinical, Translational, and Research Symposia, and abstract based Research and Topic Fora.
| IMIBD Sessions | ||
| Sunday, May 2, 2010 | Attendance | |
| Topic Forum: Microbial Composition and Pathogenic Mechanisms in Intestinal Inflammation and IBS | 8:30am-10:00am | 65 |
| Research Forum: IBD Genetics | 8:30am-10:00am | 100 |
| Cross-Sectional Topic Forum: Pediatric Gastroenterology: IBD and Inflammation | 10:30am-12:00pm | 150 |
| Research Forum: Animal Models: Mechanisms of Intestinal Inflammation | 10:30am-12:00pm | 150 |
| Research Forum: Environmental Risk Factors for IBD | 10:30am-12:00pm | 300 |
| Research Symposia: Dietary Effects on Enteric Bacterial Composition and Gene Expression | 2:15pm-3:45pm | 200 |
| Research Forum: Novel Laboratory Diagnostics in IBD | 2:15pm-3:45pm | 210 |
| Cross-Sectional Topic Forum: Prebiotics and Probiotics in the Intestine: Activities and Function | 4:00pm-5:30pm | 150 |
| Research Forum: IBD and Cancer | 4:00pm-5:30pm | 150 |
| Monday, May 3, 2010 | ||
| Research Forum: Mediation and Regulation of Intestinal Inflammation by Cytokines | 2:15pm-3:45pm | 275 |
| Research Forum: Outcomes and Adverse Events Related to Treatment of IBD | 2:15pm-3:45pm | 650 |
| Clinical Symposia: Anti-TNF Antibodies for IBD at 10 Years: A Clinician's Guide | 4:00pm-5:30pm | unknown |
| Research Forum: Surgery in IBD | 4:00pm-5:30pm | 140 |
| Tuesday, May 4, 2010 | ||
| Research Forum: Microbial/Host Interactions | 8:30am-10:00am | 82 |
| Research Forum: Endoscopy and Imaging in IBD | 8:30am-10:00am | 300 |
| Translational Symposia: Translating the New IBD Genetics into Therapy | 8:30am-10:00am | 300 |
| Research Symposia: Novel Cytokine Signaling Pathways in IBD | 10:30am-12:00pm | 175 |
| Research Forum: Clinical Trials in IBD | 10:30am-12:00pm | 2000 |
| Research Forum: Bacterial-induced Immune Responses and Signaling | 10:30am-12:00pm | 110 |
| Cross-Sectional Topic Forum: Stem Cell Biology | 2:15pm-3:45pm | 130 |
| Research Forum: Mucosal Immunoregulation and Immune-Mediated Inflammation | 2:15pm-3:45pm | 200 |
| Research Forum: Natural History and Outcomes of IBD | 2:15pm-3:45pm | 250 |
| Immunology, Microbiology and Inflammatory Bowel Diseases Distinguished Abstract Plenary | 4:00pm-5:30pm | 600 |
| Immunology, Microbiology and Inflammatory Bowel Diseases Section Business Meeting | 5:30pm-6:30pm | unknown |
| Wednesday, May 5, 2010 | ||
| Clinical Symposia: Do No Harm? Risk and the Management of IBD | 8:30am-10:00am | 400 |
| Research Forum: Immune Activation and Regulation in Intestinal Inflammation | 8:30am-10:00am | 100 |
| Research Forum: Mucosal Innate Immune Function and Innate Host Defense | 10:30am-12:00pm | 90 |
| Research Forum: Infections in IBD | 10:30am-12:00pm | 250 |
| Research Forum: Preclinical Treatment of Intestinal Inflammation in Animal Models | 2:15pm-3:45pm | 70 |
Each June, IMIBD section descriptors are reviewed to optimize scientific relevance and minimize overlapping topics with other AGA Institute Sections and to encourage both clinical research and basic science abstract submissions. The current list of abstract descriptors is as follows. (IMIBD descriptors may change as we go forward to DDW 2011.) We would like to thank our abstract review Committee Chairs and members for generously sharing their expertise and time in order to ensure that the most novel and relevant developments in Immunology, Microbiology & Inflammatory Bowel Diseases were shared at DDW.
| Descriptor Name | Abstracts Received | Abstract Review Chair | Abstract Reviewers |
| IBD: Diagnostics in IBD | 40 | Willem de Villiers | Jonathan Leighton, Iris Dotan, Laurent Peyrin-Biroulet |
| IBD: Disease Activity Assessment | 32 | Peter Higgins | Thomas Ullman, Simon Travis, Anne Griffiths |
| IBD: Disease Complications and Outcomes | 100 | Hillary Steinhart | Laurent Beaugerie, Miguel Regueiro, Remo Panaccione |
| IBD: Adverse Events Related to Therapy | 30 | Charles Bernstein | David Rubin, Corey Siegel, Daniel Baumgart |
| IBD: Epidemiology and Natural History | 82 | Athos Bousvaros | Michael Kapelman, Gil Kaplan, Geoffrey Nguyen |
| IBD: Uncontrolled Therapeutic Observations in Humans | 83 | Joshua Korzenik | Gil Melmed, Ashwin Ananthakrishnan, Fernando Velayos |
| IBD: Controlled Clinical Trials in Humans | 35 | William Sandborn | Marc Lemann, Geert van Assche, Hans Herfarth |
| IBD: Genetics | 57 | Judy Cho | Vito Annese, Mark Silverberg |
| IBD: Immune Activation and Regulation | 57 | Giovanni Monteleone | Takanori Kanai, Stefan Schreiber, Claudio Fiocchi |
| IBD: Therapeutic Monitoring | 29 | Uma Mahadevan | Geert D'Haens, Jean-Frederic Colombel, Sunanda Kane |
| Animal Models: Mechanisms of Intestinal Inflammation | 68 | Lee Denson | Paul Beck, Matthew B. Grisham, Atsushi Mizoguchi |
| Animal Models: Pre-Clinical Treatment of Intestinal Inflammation | 50 | Pawel R. Kiela | John Wallace, Jesus Rivera-Nieves, David E. Elliott |
| Epithelial Cell Immune Function and Interactions with Immune Cells and Microbial Agents | 31 | Kim Barrett | Elke Cario, Richard Blumberg, Gerhard Rogler |
| IBD: Non-immune Cell Function, Activation and Regulation | 28 | Barry K. Wershil | Jay Kuemmerle, Ellen Zimmerman |
| IBD: Cytokines, Signaling and Receptors | 45 | Scott Snapper | Christian Jobin, David L. Boone, Hans-Christian Reinecker |
| Mucosal Innate Immune Function and Innate Host Defense | 38 | Averil Ma | Maria Abreu, Scott Plevy |
| Mucosal Lymphocyte Function and Regulation: Animal Models and in Vitro Studies | 12 | Mamoru Watanabe | Monica Boirivant, Clara Abraham, Fabio Comivelli |
| Microbial-Induced Mucosal Inflammation and Immunity | 59 | Jon Braun | Sarkis K. Mazmanian, Charles O. Elson, Ingo Autenrieth |
| Prebiotics and Probiotics (Cross-section descriptor) | 17 | Karen Madsen | Andrew Gewirtz, Elena Verdu, Martin Floch |
| Pediatric IBD: Clinical and Translational Studies (Cross-section descriptor) | 12 | Francisco Sylvester | Sandra Kim, Subra Kugathasan |
| Stem Cell Biology (Cross-section descriptor) | 6 | Michael Choi | Steve Cohn, Bart Rountree, Tim Wang, Courtney Houchen |
Section leaders will review committee membership this summer for abstract review committees to confirm the final composition for DDW 2011 committees.
IMIBD section members interested in serving in this capacity are encouraged to contact us and volunteer to review abstracts.
Please submit your invaluable ideas about the topics and invited speakers that you would like to hear at next year's DDW. The more specific you can be, the better (title, individual talks, speakers, learning objectives). Please forward your suggestions to John Whiton, AGA Institute by July 6, 2010.
Members interested in participating in the various activities of the Section should contact us at the addresses below. We are particularly interested in increasing participation by junior investigators/clinicians and international members at this time.
If you are interested in serving as a reviewer for any of our abstract descriptors, please let us know. Please cite the abstract descriptor for which you would be interested in reviewing. Please recommend any new descriptors for abstracts.
Thank you for your continuing strong support of the Immunology, Microbiology & Inflammatory Bowel Diseases Section.
Sincerely,
Bruce E. Sands, MD, MS, AGAF
Chair, IMIBD Section, AGA Institute Council
Maria T. Abreu, MD
Vice-Chair, IMIBD Section, AGA Institute Council